A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial

NCT01696214 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone 250 mg/salmeterol 50 mg
DRUG: Montelukast 10mg
DRUG: Theophylline 400 mg
DRUG: ipratropium

Sponsor

University of California, San Diego

Collaborators

[object Object]